Headquartered in the US with an R&D center in India, LeadInvent Pharma offers drug development and pharma science services. They have created a unique gel that is applied onto the tumor resected cavity to kill cancer cells upon getting excited with a low power laser. The gel bypasses the blood-brain barrier and reduces systemic exposure. In preliminary toxicity studies, the gel was well tolerated with no observed side-effects at the treatment dose.